A cooperative study demonstrates that CAR-T cell therapy is safe and effective, even for patients who are at high risk.

Published Date: 13 Dec 2023

For patients with diffuse large B-cell lymphoma (DLBCL), even those considered high risk because of comorbidities, CAR-T cell therapy is a safe and successful mode of treatment.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Researchers find distinct cell receptors with the potential for new treatments.

2.

Breast cancer patients' arms swell less after an effective lymph node transfer.

3.

Telehealth in the pandemic era resulted in fewer therapy interruptions.

4.

Too Many Chest CTs for Incidental Lung Nodules?

5.

Global warming could be driving up women's cancer risk, find researchers


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot